NONALCOHOLIC STEATOHEPATITIS
Clinical trials for NONALCOHOLIC STEATOHEPATITIS explained in plain language.
Never miss a new study
Get alerted when new NONALCOHOLIC STEATOHEPATITIS trials appear
Sign up with your email to follow new studies for NONALCOHOLIC STEATOHEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a blood pressure pill protect the liver from cancer?
Disease control OngoingThis study tests whether lisinopril, a widely used blood pressure medication, can slow liver scarring in people with non-alcoholic fatty liver disease (NAFLD). The goal is to see if it reduces the risk of liver cancer. About 45 adults with advanced liver scarring are taking lisin…
Matched conditions: NONALCOHOLIC STEATOHEPATITIS
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 26, 2026 09:29 UTC
-
New drug shows promise against fatty liver cirrhosis
Disease control OngoingThis study tests an experimental drug called efinopegdutide in 80 adults with liver scarring (cirrhosis) caused by a type of fatty liver disease (MASH). The goal is to see if the drug can lower liver fat, inflammation, and scarring over about 7 months. Participants will receive e…
Matched conditions: NONALCOHOLIC STEATOHEPATITIS
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Hidden liver risk in type 1 diabetes: new study uses painless scans to find fatty liver and scarring
Knowledge-focused OngoingThis study looks at how often nonalcoholic fatty liver disease (NAFLD) and advanced liver scarring occur in adults with type 1 diabetes. About 533 participants from a diabetes clinic will get a quick, painless liver scan and blood tests. The goal is to find those at highest risk …
Matched conditions: NONALCOHOLIC STEATOHEPATITIS
Sponsor: Joslin Diabetes Center • Aim: Knowledge-focused
Last updated May 26, 2026 09:30 UTC